Home   |   Company Profile   |   Products   |   Contact us       Eipico For Pharmaceutical Industrial
Company Profile
Profile
Chairman
Eipico Expansions
Export Activities

Balance Sheet & Income   

More
License Agreements
Export

GMP & ISO

Products
Products
 
Contact us
Contact us

 

 

  Balance Sheet  

    
AS AT 31 DECEMBER 1998

1998 LE

1997LE

Gross Fixed Assets

169 846 826

153 217 434

Less Accumulated Depreciation

79 001 230

65 098 531

Net Fixed Assets

90 845 596

88 118 903

Projects in Progress

32 316 479

16 995 262

Other Assets

2 786 788

4 185 044

* Current Assets
Inventories

144 833 157

110 904 266

Other Current Assets

10 720 324

7 094 349

Investments

370 000

370 000

Accounts Receivable & Prepayments

142 644 211

144 524 125

Bank Operating Cash

9 314 916

32 143 786

Total Assets

433 831 471

404 335 735

* Current Liabilities
Short-Term Bank Debit

9 305 805

13 319 316

Accounts Payable

6 930 528

6 233 278

Dividends Payable & Appropriations

72 808 057

71 150 812

Other Current Liabilities

27 138 929

20 971 568

Total Current Liabilities

116 183 319

111 674 974

Total Provisions

122 539 424

112 137 424

Paid In Capital

42 000 000

42 000 000

Reserves

153 085 808

138 115 737

Retained Earnings

22 920

407 600

Total Shareholder's Equity

195 108 728

180 523 337

Total Liabilities & Shareholder's Equity

433 831 471

404 335 735

  Income Statement       
INCOME STATEMENT AND RETAINED EARNINGS
YEAR ENDED 31 DECEMBER 1998

1998 LE

1997 LE

Statement of Income
Net Sales

344 421 074

305 514 023

Selling and Distribution Expenses

33 948 110

28 973 272

Gross Profit

122 541 333

104 418 606

Other Expenses

8 696 398

7 790 182

General Administrative

1 944 359

1 276 395

Financing Expenses

3 297

5 650

Real estate Tax

3 366 754

19 132

Donations & Settlement of claims

9 415 537

9 532 833

Provisions

( 388 153)

( 188 452)

Investment Income & Others

*1 103 156

3 551 430

Interest Income

*1 395 888

585 915

Interest Expense

292 292

(2 965 515)

Net Interest

23 330 484

15 470 225

Net Profit before Tax

99 210 849

88 948 381

Income Tax

15 132 362

13 126 105

Net Profit after Tax

84 078 487

75 822 276

Statement of Retained Earnings
Net operated profit for the year

84 078 487

75 822 276

Opening Balance

407 600

--

84 486 087

75 822 276

Transfer to statury Reserve

4 203 924

3 791 114

Transfer to general Reserve

8 535 000

5 000 000

Proposed dividend

63 000 000

58 800 000

Appropriations

8 724 243

8 001 212

84 463 167

75 592 326

Closing Balance (retained earnings at Dec.)

22 920

229 950

 
     Back